InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Maze Therapeutics, Inc.

MAZE Clue Score57
United States Fiscal year ends December CIK 0001842295 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Harold Bernstein
3 Sep 2026
President, R&D & CMO
Sell
59
$25.78
$1.52K
Harold Bernstein
3 Sep 2026
President, R&D & CMO
Sell
5,130
$26.01
$133.45K
Jason Coloma V
3 Sep 2026
Chief Executive Officer
Sell
129
$25.77
$3.32K
Jason Coloma V
3 Sep 2026
Chief Executive Officer
Sell
11,282
$26.01
$293.48K
Atul Dandekar
3 Sep 2026
Csbo
Sell
36
$25.81
$929.16
Atul Dandekar
3 Sep 2026
Csbo
Sell
3,207
$26.01
$83.42K
Phillips Courtney
3 Sep 2026
GC and Corp. Secretary
Sell
22
$25.78
$567.16
Phillips Courtney
3 Sep 2026
GC and Corp. Secretary
Sell
1,990
$26.01
$51.77K
Harold Bernstein
2 Sep 2026
President, R&D & CMO
Sell
625
$27.12
$16.95K
Harold Bernstein
2 Sep 2026
President, R&D & CMO
Sell
4,481
$26.38
$118.19K
Jason Coloma V
2 Sep 2026
Chief Executive Officer
Sell
1,375
$27.12
$37.29K
Jason Coloma V
2 Sep 2026
Chief Executive Officer
Sell
9,852
$26.38
$259.86K
Atul Dandekar
2 Sep 2026
Csbo
Sell
391
$27.12
$10.60K
Atul Dandekar
2 Sep 2026
Csbo
Sell
2,800
$26.38
$73.85K
Phillips Courtney
2 Sep 2026
GC and Corp. Secretary
Sell
243
$27.12
$6.59K
Phillips Courtney
2 Sep 2026
GC and Corp. Secretary
Sell
1,738
$26.38
$45.84K
Show all 102 transactions →

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 60
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 574,015
History held since 4 Feb 2025